Navigation Links
Vaccine To Protect Against Cervical Cancer Approved

For the first time women will have a vaccine to protect themselves from cervical cancer as the United States has approved the sale of 'Gardasil' produced by American pharmaceutical giant Merck. //

The Food and Drug Administration has approved the use of the vaccine, Gardasil, for use in girls and women ages 9 to 26 under its priority review process which allows an early release of products with potential to provide significant benefits.

Gardasil is a recombinant vaccine (contains no live virus) that is given as three injections over a six-month period and it works by preventing infection by four strains of the human papillomavirus, or HPV, the most prevalent sexually transmitted disease.

However, females are not protected if they have been infected with that HPV type(s) prior to vaccination, indicating the importance of immunization before potential exposure to the virus.

Also, Gardasil does not protect against less common HPV types not included in the vaccine, thus routine and regular PAP screening remain critically important to detect precancerous changes in the cervix to allow treatment before cervical cancer develops.

'Not only have vaccines dramatically reduced the toll of diseases in infants and children, like polio and measles, but they are playing an increasing role protecting and improvi ng the lives of adolescents and adults,' Jesse Goodman, Director of FDA's Center for Biologics Evaluation and Research, said.

(Source:PTI News)
'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...tario will soon become the first province in Canad... who have died of heart failure//. The provincial...nounced that changes in guidelines that allowed ac...irculatory death (DCD) could potentially expand th...
... enhance the success rate of transplant surgeries,...n removal. Now, The Australian Health Ethics Commi...for medical procedures to be conducted on patients...tor, with a motive to remove organs before it dete...
... going study with radioactive version of scorpion ...in gliomas. Scientists at the Transmolecular Corp...version of a protein resembling the yellow Israeli...M-601, as a safer and different way to destroy pro...
...e diagnosis of Tuberculosis in a health worker in ... testing of more than 200 babies//. TB is a curab...weight loss, fatigue and fevers. It usually affect... years. Elizabeth Garrett Anderson and Obstetric H...
Other Medicine News:Health News:Ontario Addresses Shortage of Transplant Organs 2Health News:Brain Cancer Could be Safely Treated with Radioactive Scorpion Venom 2
(Date:8/27/2008)...night in Parts of Bucks, Delaware, Montgomery,Phi...ewswire-USNewswire/ -- After encouraging,results f... Department of,Environmental Protection will conti... against the mosquito-borne West Nile virus., Tar...en 8 p.m. and,midnight in portions of Bucks, Delaw...
(Date:8/27/2008)... Team Makes Crucial Breakthrough in Battle to Prev...ase, CHICAGO, Aug. 27 /- The British...that scientists at The University of Nottingham,ha...ow or prevent the onset,of a very common type of d... have genetically produced the first ever mouse mo...
(Date:8/27/2008)...ata, from BLISS-52 trial, expected by mid-2009 - ...ed by fall 2009 -, ROCKVILLE, Md., Aug. 27 /PRNew...asdaq: HGSI ) today announced it has completed en...d of two pivotal Phase 3,randomized clinical trial...active systemic lupus erythematosus (SLE). Belimum...
(Date:8/26/2008)... 26 /- Semafore Pharmaceuticals Inc.,...nal Congress on Targeted,Therapies in Cancer in Wa...activity of vascular-targeted PI3 kinase (PI3K) in...aling., PI3K is part of a very powerful pathway, ...lay a major role in cancer. Studies have shown tha...
Breaking Medicine Technology:DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 2DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 3The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco 2555 1Northwest Biotherapeutics Inc Announces Appointment of Chief Financial Officer 972 1Northwest Biotherapeutics Inc Announces Appointment of Chief Financial Officer 972 2New USAID grant helps Georgetown meet unmet family planning needs worldwide 2554 1New USAID grant helps Georgetown meet unmet family planning needs worldwide 2554 2Kerry Extends Improves Small Business Innovation Program 2552 1Kerry Extends Improves Small Business Innovation Program 2552 2
Fill offers an economical, compact, and reliable alternative to existing microplate dispensers. Fill guarantees accurate and precise dispensing without the time-consuming recalibration and maintenanc
...mated dispenser for Deep Well plates, 1.1 ml test ...d precision, the Multidrop DW dispenses up to eigh...20-995 l. Multidrop DW allows continuous dispensin...spense directly from single or multiple reagent bo...
TargetScan(R) is the latest innovation in prostate mapping, biopsy and cancer treatment guidance. Combining 3-D image acquisition with a stationary probe, this new technology helps physicians plan an
The Applied Biosystems 9800 Fast Thermal Cycler is an integral component of the Applied Biosystems 9800 Fast PCR System, which reduces PCR reaction time from 2 hours to as little as 25 minutes -- mov
Medicine Products: